Sign In
Buy ITRM
$0.0300
+0 (+0%)
At Close: Jun 30, 2026
The Week Ahead In Biotech (April 26-May 2): Cancer Conference, Earnings News Flow In The Spotlight
08:37pm, Sunday, 26'th Apr 2020
The week ended April 24 turned out to be an up-and-down one for biotech stocks, as the sector swayed along with the broader market. Two FDA approvals came through this week, with Immunomedics, Inc.'s
The Week Ahead In Biotech: Urogen FDA Decision, Amarin, J&J Earnings And More COVID-19 Updates
05:44pm, Sunday, 12'th Apr 2020
Biotech stocks moved higher last week along with the broader market. The week witnessed a few clinical readouts and pre-announcements that reflected the coronavirus (COVID-19) impact.
Iterum Therapeutics to Present at the 19th Annual Needham Virtual Healthcare Conference
08:05pm, Thursday, 09'th Apr 2020
DUBLIN, Ireland and CHICAGO, April 09, 2020 -- Iterum Therapeutics plc (Nasdaq: ITRM), a clinical-stage pharmaceutical company focused on developing next generation oral and IV.
Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks that hit 52-week highs March 30.) * Athersys Inc (NASDAQ: ATHX) (reacted to $7-milli
Iterum Therapeutics plc (ITRM), a clinical-stage pharmaceutical company focused on developing next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens in bo
The Week Ahead In Biotech: Clinical Readouts, COVID-19 News Flow In Focus Amid Continuing Uncertainty
04:10pm, Sunday, 29'th Mar 2020
After starting the week ended March 28 on the backfoot, biotech stocks recovered through the week. Activity in the space remained light, although coronavirus (COVID-19) news flow continued to dominate
Analysts Are Bullish on These Healthcare Stocks: Iterum Therapeutics (ITRM), Pluristem (PSTI)
05:48pm, Friday, 13'th Mar 2020
There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Iterum Therapeutics (ITRM) and Pluristem (PSTI) with
Analysts Are Bullish on These Healthcare Stocks: Iterum Therapeutics (ITRM), Pluristem (PSTI)
05:48pm, Friday, 13'th Mar 2020
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Iterum Therapeutics (
ITRM
–
Research Report
) and Pluristem (
PSTI
–
Research Report
) with bullis
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Lexicon Pharmaceuticals (LXRX) and Iterum Therapeutics
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Lexicon Pharmaceuticals (LXRX
Iterum Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results
10:45am, Thursday, 12'th Mar 2020
--Topline data from cUTI and uUTI pivotal trials on track to report around the end of Q1----NDAs anticipated to file with the FDA in mid-2020-- DUBLIN, Ireland and.
Iterum Therapeutics to Present at the 9th Annual SVB Leerink Global Healthcare Conference
12:30pm, Wednesday, 19'th Feb 2020
DUBLIN, Ireland and CHICAGO, Feb. 19, 2020 -- Iterum Therapeutics plc (Nasdaq: ITRM), a clinical-stage pharmaceutical company focused on developing next generation oral and IV.
Iterum Therapeutics Announces $52 Million Private Placement with New and Existing Investors
11:15am, Friday, 17'th Jan 2020
Iterum Therapeutics plc (ITRM) (the “Company”), a clinical-stage pharmaceutical company focused on developing next generation oral and IV antibiotics to treat infections caused by multi-drug resis
Riding December's Momentum Into 2020
08:15pm, Friday, 03'rd Jan 2020
The other big momentum stock from last Friday, Iterum Therapeutics plc (NASDAQ: ITRM), was a lower float stock popped up out of nowhere on my intraday momentum scanner. As soon as it started trading
Iterum Therapeutics plc (ITRM), a clinical-stage pharmaceutical company focused on developing next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens in bo
